[1]
“In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach”, Chem Biol Lett, vol. 7, no. 3, pp. 166–175, Mar. 2020, Accessed: May 04, 2024. [Online]. Available: https://pubs.thesciencein.org/journal/index.php/cbl/article/view/136